Chronic urticaria can significantly impact daily life, especially when symptoms are triggered by cold exposure or minor skin friction. Research studies play a key role in helping scientists better understand these conditions and develop new treatment strategies.
The EMBARQ Study is a Phase 3 trial evaluating an investigational medication for adults with ColdU and symptomatic dermographism. By participating, volunteers help researchers collect valuable data that may guide future treatment options.
Every clinical trial follows strict safety standards, and participants remain in control of their involvement throughout the process. Research like this helps move science forward and brings hope to individuals living with challenging conditions.